The influence of Rhodiola quadrifida 50 per cent hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice

• Autorzy: Skopinska-Rozewska E. , Malinowski M. , Wasiutynski A. , Sommer E. , Furmanowa M. , Mazurkiewicz M. , Siwicki A.K.
• Języki publikacji: EN

Abstrakty

EN

The genus Rhodiola (Crassulaceae) consists of more than 100 species. They grow mainly in Tibet, China and Mongolia and are traditionally used as tonic, adaptogen , antidepressant and anti-inflammatory drugs. The best known is Rhodiola rosea (R. rosea) now cultivated also in Europe and North America, and present on the market as dietary supplement. Some authors reported anti-tumor activity of R. rosea extracts. Recently, we have published some data on immunomodulatory and antiangiogenic properties of R. rosea. Rhodiola quadrifida (R. quadrifida) belongs to the same family, but is almost not known in Europe, and there is no information about its possible anti-tumor as well as immunotropic and angiotropic activity. The aim of this study was to determine the influence of 50% hydro-alcoholic extract from rhizomes of R. quadrifida (Mongolian origin) and its main biologically active compound salidroside on tumor-induced angiogenesis. Angiogenesis was induced in the skin of Balb/c mice by grafting of syngeneic L-l sarcoma cells. Mice were fed R. quadrifida extract or salidroside in daily doses 40, 200 and 400 μg, or 0.5, 1, 2, and 4 μg, respectively. After 72 hours, mice were sacrificed with lethal dose of Morbital. All newly formed blood vessels were identified and counted in dissection microscope. Results: It was found that R. quadrifida extract and salidroside highly significantly decreased neovas- cular reaction in all doses applied.

Słowa kluczowe

EN

mice; mouse; laboratory animal; tumour-induced angiogenesis; angiogenesis; tumour cell; Rhodiola quadrifida; hydro-alcoholic extract; salidroside

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2008
• Tom: 11
• Numer: 2
• Strony: 97-104
• Opis fizyczny: p.97-104,fig.,ref.

Twórcy

autor

Skopinska-Rozewska E.

• Medical University, Chalubinskiego 5, 02-004 Warsaw, Poland

autor

Malinowski M.

autor

Wasiutynski A.

autor

Sommer E.

autor

Furmanowa M.

autor

Mazurkiewicz M.

autor

Siwicki A.K.

Bibliografia

• Ahmad N, Mukhtar H (1999) Green tea polyphenols and cancer: Biologic mechanisms and practical implica­tions. Nutr Rev 57: 78-83.
• Aoki M, Kanamori M, Yudoh K, Ohmori K, Yasuda T, Kimura T (2001) Effects of vascular endothelial growth factor and E-selectin on angiogenesis in the murine metastatic RCT sarcoma. Tumor Biol 22: 239-246.
• Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. (1995) Synergistic ef­fect of vascular endothelial growth factor and basic fi­broblast growth factor on angiogenesis in vivo. Circula­tion 92: 365-371.
• Balan BJ, Skopińska-Różewska E, Barcz E, Sokolnicka I, Gawrychowski K, Strzelecka H (1999) The effect of selected phenolic acids on angiogenic activity of ovar­ian cancer cells- preliminary report. Onkol Pol 2: 203-208.
• Balan BJ, Skopińska-Różewska E, Domański J, Skurzak H, Snitkowska E, Sommer E (2001) Assessment of anti-angiogenic activity of multicomponent herbal preparation „Pervivo” using digital computer image analysis. Terapia IX (3/2) : 21-22.
• Balasubramanian L, Evens AM (2006) Targeting an­giogenesis for the treatment of sarcoma. Curr Opin Oncol 18: 354-359.
• Bany J, Skopińska-Różewska E, Chorostowska-Wynimko J, Rogala E, Sommer E, Zdanowska D, Filewska M, Skurzak H (2004) The effect of complex herbal remedy on the angiogenic activity of L-l sarcoma cells, L-l sar­coma tumor growth, and on the bacterial infection in mice. Centr Eur J Immunol 29: 29-34.
• Barcz E, Sommer E, Janik P, Marianowski L, Skopińska-Różewska E (2000) Adenosine receptor an­tagonism causes inhibition of angiogenic activity of hu­man ovarian cancer cells. Oncology Reports 7: 1285-1291.
• Bocharova OA, Matweev BP, Baryshnikov AI, Figurin KM, Serebriakova RV, Bodrova NB (1995) The effect of a Rhodiola rosea extract on the incidence of recur­rences of a superficial bladder cancer. Urol Nefrol (Mosk) 2: 46-47.
• Carmeliet P (2005) VEGF as a key mediator of angiogen­esis in cancer. Oncology 69: 4-10.
• Chung S Yang, Jee Y Chung, Guang-yu Yang, Saranjit K Chhabra, Mao-Jung Lee (2000) Tea and tea poly­phenols in cancer prevention. J Nutr 130: 472-478. Demeule M, Brossard M, Page M, Gingras D, Beliveau R (2000) Matrix metalloproteinase inhibition by green tea catechins. Biochem Biophys Acta 1478: 51-60. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR (1995) Vascular permeability fac­tor vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflamma­tion. Int Arch Allergy Immunol 107: 233-235.
• Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Seminars in Oncology 29: 15-18.
• Folkman J (2003) Angiogenesis inhibitors: a new class of drugs. Cancer Biol Ther 2: 127-133.
• Gasparini G (1999) The rationale and future potential of angiogenesis inhibitors in neoplasia. Drugs 58: 17-38.
• Gil M, Skopińska-Różewska E, Radomska D, Demkow U, Skurzak H, Rochowska M, Beuth J, Roszkowski K (1993) Effect of purinergic receptor antagonists Suramin and Theobromine on tumor-induced an­giogenesis in Balb/c mice. Folia Biologica 39: 63-68.
• Hoser G, Furmanowa M, Urbańska N, Pietrosiuk A, Zobel A, Kuraś M (2006) Antiproliferative and antimitotic effect, S phase accumulation and induction of apopto­sis and necrosis after treatment of extract from Rho­diola rosea rhizomes on HL-60 cells. J Ethnophar- macol 103: 43- 52.
• Kamiński MJ, Bem W, Majewski S, Kamińska G, Szmurlo A (1981) Angiogenesis induction by xenogenic lym­phoid and non-lymphoid cells in mice. Arch Immunol Ther Exp 29: 521-523.
• Kim S, Lee MJ, Hong J, Li C, Smith TJ, Yang GY, Serii DN, Yang CS (2000) Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer 37: 41-48.
• Kimura I (2006) Medical benefits of using natural com­pounds and their derivatives having multiple pharma­cological actions. Yakugaku Zasshi 126: 133-143.
• Kucinskaite A, Briedis V, Savickas A (2004) Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine. Medicina 40: 614-19.
• Lambert JD, Churug SY (2003) Cancer chemopreventive activity and bioavailability of tea polyphenols. Muta­tion Res 523-524: 201-208.
• Maeda-Yamamoto M, Kawahara H, Tahara N, Tsuji K, Hara Y, Isemura M (1999) Effects of tea polyphenols on the invasion and matrix metalloproteinases activ­ities of human fibrosarcona HT1080 cells. J Agric Food Chem. 47: 2350-2354.
• Malonne H, Langer I, Kiss R, Atassi G (1999) Mechan­isms of tumor angiogenesis and therapeutic implica­tions: angiogenesis inhibitors. Clin Exp Metastasis 17: 1-14.
• Milkiewicz M, Ispanovic E, Doyle JL, Haas TL (2006) Regulators of angiogenesis and strategies for their therapeutic regulation. Int J Biochem Cell Biol 38: 333-357.
• Ming DS, Hillhouse BJ, Guns ES, Eberding A, Xie S, Vimalanathan S, Towers GH (2005) Bioactive com­pounds from Rhodiola rosea (Crassulaceae). Phytother Res 19: 740-743.
• Nartowska J, Sommer E, Siwicki AK, Bany J, Skurzak H, Augustynowicz J, Skopińska-Różewska E (2005) The anti-angiogenic and immunotropic properties of conva- llamaroside, a steroidal saponin isolated from rhizomes and roots of Convallaria majalis L. Pol J Environ Stud 14: 296-299.
• Razina TG, Zueva EP, Amosova EN, Krylova SG (2000) Medicinal plant preparations used as adjuvant thera­peutics in experimental oncology. Eksp Klin Farmakol 63: 59-61.
• Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, Liu C, Ellis L, Liu W, Go VL, Brooks MN (2002)
• Green tea inhibits vascular endothelial growth factors (VEGF) induction in human breast cancer cells. J Nutr 132: 2307-2311.
• Sidky YA, Auerbach R (1975) Lymphocyte-induced an­giogenesis: a quantitative and sensitive assay of the graft-vs-host reaction. J Exp Med 141: 1084-1100.
• Siemeister G, Martiny-Baron G, Marme D (1998) The pivotal role of VEGF in tumor angiogenesis: Molecular facts and therapeutic opportunities. Cancer Metastasis Rev 17: 241-248.
• Siwicki AK, Skopińska-Różewska E, Nartowska J, Malac- zewska J, Wójcik R, Sommer E, Trapkowska S, Filewska M, Skurzak H (2004) Effect of Immunostim Plus - a standarized fixed combination of Schizandra chinensis with Eleutherococcus Senticosus extracts on granulocyte activity and tumor angiogenesis in mice. Bull Vet Inst Puławy 48: 489-492.
• Siwicki AK, Skopińska-Różewska E, Hartwich M, Wójcik R, Bakuia T, Furmanowa M, Balan BJ, Sommer E, Mielcarek S, Buchwald W, Krajewska-Patan A, Mścisz A, Mrozikiewicz PM, Bany J (2007) The influence of Rhodiola rosea extracts on non-specific and specific cellular immunity in pigs, rats and mice. Centr Eur J Immunol 32: 84-91.
• Skopińska-Różewska E, Sommer E, Balan BJ, Skopiński P, Demkow U (1995) Methyloxantines as angiogenesis inhibitors. International J Oncol 7(Suppl): 949.
• Skopińska-Różewska E, Sommer E, Demkow U, Choros- towska-Wynimko J, Balan B, Różycka B, Barcz E, Filewska M, Mlekodaj S, Rudziński P, Seweryniak W, Caban P, Kupis W, Bogdan J, Usiekniewicz P, Gatarek J, Langfort R (1997) Screening of angiogenesis inhibi­tors by modified tumor-induced angiogenesis (TIA) test in lung cancer. Roczniki Akademii Medycznej w Białymstoku 42: 287-296.
• Skopińska-Różewska E, Piazza GA, Sommer E, Pamukcu R, Barcz E, Filewska M, Kupis W, Caban R, Rudziński P, Bogdan J, Mlekodaj S, Sikorska E (1998a) Inhibi­tion of angiogenesis by Sulindac and its sulfone meta­bolite (FGN-1): A potential mechanism for their anti- neoplastic properties. Int J Tissue React 20: 85-89.
• Skopińska-Różewska E, Janik P, Przybyszewska M, Som­mer E, Bialas-Chromiec B (1998b) Inhibitory effect of Theobromine on induction of angiogenesis and VEGF mRNA expression in v-ra/ transfectants of human urothelial cells HCV-29. Int J Mol Med 2: 649-652.
• Skopińska-Różewska E, Krotkiewski M, Sommer E, Roga­la E, Filewska M, Bialas-Chromiec B, Pastewka K, Skurzak H (1999) Inhibitory effect of shark liver oil on cutaneous angiogenesis induced in Balb/c mice by syn­geneic sarcoma L-l, human urinary bladder and human kidney tumor cells. Oncol Rep 6: 1341-1344.
• Skopińska-Różewska E, Chorostowska-Wynimko J, Krot­kiewski M, Rogala E, Sommer E, Demkow U, Skurzak H (2003) Inhibitory effect of Greenland Shark Liver Oil combined with Squalen and Arctic birch ashes on angiogenesis and L-l Sarcoma growth in Balb/c mice. Pol J Vet Sci 6: 54-56.
• Skopińska-Różewska E, Nartowska J, Wojtasik E, Som­mer E, Balan BJ, Bany J, Demkow U, Skopiński P, Siwicki AK, Mierzwińska E, Demkow T, Skurzak H, Pastewka K, Bialas-Chromiec B, Filewska M, Matczak A (2006) Poszukiwanie inhibitorów angiogenezy
• nowotworowej wśród leków naturalnych o własnościach immunomodulujących. In: Siwicki AK, Skopińska- -Różewska E (ed) Naturalne i syntetyczne modulatory odpowiedzi immunologicznej i angiogenezy. SPW EDYCJA Publishers, Olsztyn, pp 7-26.
• Skopińska-Różewska E, Skurzak H, Wasiutyński A, Jung L, Siwicki AK, Balan BJ, Sommer E, Mazurkiewicz M, Skorupski M, Prątnicki A, Sokolnicka I, Skopiński P (2007) Sarcoma L-l in mice as a model for the study of experimental angiogenesis. Centr Eur J Immunol 32: 77-83.
• Skopińska-Różewska E, Hartwich M, Siwicki A, Wasiutyński A, Sommer E, Mazurkiewicz M, Bany J, Skurzak H (2008) The influence of Rhodiola rosea ex­tracts and rosavin on cutaneous angiogenesis induced in mice by grafting of syngeneic tumor cells. Centr Eur J Immunol 33(3): 102-107.
• Skopiński P, Szaflik J, Duda-Król B, Nartowska J, Sommer E, Chorostowska-Wynimko J Demkow U, Skopińska-Różewska E (2004) Suppression of an­giogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone. Int J Molecular Medicine 14: 707-711.
• Skopiński P, Skopińska-Różewska E, Sommer E, Siwicki AK, Wasiutyński A (2005) The effect of some diet-de­rived angiogenesis inhibitors and sulindac sulfone on the ability of VEGF, bFGF and IL-18 to induce cutaneous neo-vascular response in mice. Pol J Environ Stud 14 (Suppl 2): 325-329.
• Sommer E, Skopińska-Różewska E, Skurzak H (2001) The effect of linoleic acid on the growth and vascularity of L-l sarcoma in mice and on the cutaneous angiogen­esis induced by tumor cells. Współczesna Onkologia 5: 250-253.
• Sounni NE, Devy L, Hajitou A, Frankenne F, Munaut C, Gilles C, Deroanne C, Thompson EW, Foidart JM, Noel A (2002) MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 16: 555-564.
• Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H (1999) Synergistic effects of epigallocatechin gallate with epicatechin, sulindac, or tamoxifen on cancer-pre­ventive activity in the human lung cancer cell line PC-9. Cancer Res 59: 44-47.
• Sui XL, Yang F, Chen RH, Ga B, Yan H, Zhang SF, Zhang JL (2006) Inhibition of Rhodiola on the growth of EVC-304 cell line. XI Bao Yu Fen Zi Mian Yi Xue Za Zhi 22: 524-525.
• Thompson WD, Li WW, Maragoudakis M (1999) The cli­nical manipulation of angiogenesis: pathology, side ef­fects, surprises and opportunities with novel human therapies. J Pathol 187: 503-510.
• Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, ligo M, Takasuka N, Moore MA (2004) Cancer pre­vention by natural compounds. Drug Metab Phar- macokinet 19: 245-263.
• Wasiutyński A, Siwicki AK, Balan BJ, Sommer E, Bany J, Wąsik M, Prątnicki A, Skurzak H, Skopińska-Różewska E (2005) Inhibitory effect of co­coa catechins on embryonic and tumor angiogenesis in mice. Pol J Environ Stud 14 (Suppl 2): 800-805.
• Wasiutyriski A, Skopinska-Rozewska E, Jung L, Sommer E, Bany J, Siwicki AK, Chorostowska-Wynimko J, Prqtnicki A, Morton M, Skurzak H (2006) Comparison of the effects of Enoxaparin and Nadroparin on tumor angiogenesis in mice. Centr Eur J Immunol 31: 70-74.
• Wiedenfeld H, Dumaa M, Malinowski M, Furmanowa M, Narantuya S (2007) Phytochemical and analytical stu­dies of extracts from Rhodiola rosea and Rhodiola quadrifida. Pharmazie 4: 308-311.